Are COVID-19 treatment pills reaching the communities that need them most?

When COVID-19 antiviral pills became available, a big question was whether they would reach everyone equally. A new study tried to answer that by looking at dispensing trends across U.S. zip codes, specifically checking if areas with higher social vulnerability—often facing more barriers to healthcare—were getting these drugs. The researchers mapped where the pills were going, but the actual findings about any patterns or disparities have not been released yet. Without the results, we can't say if there's a problem with access or if the system is working fairly. This kind of information is crucial because these treatments need to get to the people at highest risk, wherever they live.